Search Results for "poverty guidelines"
Displaying 21 - 40 of 75 results. 20 results shown per page. Page 2 of 4.
CDC — Fluoroquinolone: HHS Response to Rfc
Publication Date
March 13, 2003 Kent D. McClure, DVM, JD General Counsel Animal Health Institute 1325 G. Street, NW, Ste. 700 Washington, DC 20005-3104
NTP — Nickel: Interim Response, March 10, 2004
Publication Date
March 10, 2004 Mr. Neil J. King Wilmer, Cutler & Pickering 2445 M. St. N.W. Washington, D.C. 20037-1420 RE: Request for Reconsideration Submitted November 17, 2003 Dear Mr. King:
NTP — Nickel: Interim Response, May 6, 2004
Publication Date
May 6, 2004 Mr. Neil J. King Wilmer, Cutler & Pickering 2445 M. St. N.W. Washington, D.C. 20037-1420 RE: Request for Reconsideration Submitted November 17, 2003 Dear Mr. King:
NTP — Nickel: Interim Response, September 1, 2004
Publication Date
September 1, 2004 Mr. Neil J. King Wilmer, Cutler & Pickering 2445 M. St. N.W. Washington, D.C. 20037-1420 RE: Request for Reconsideration Submitted November 17, 2003 Dear Mr. King:
CDC/ATSDR — Formaldehyde Levels: b.5. Interim Response
Publication Date
Betsy M. Natz Executive Director Dear Ms. Natz:
CDC/ATSDR — Formaldehyde Levels: b.6. Interim Response
Publication Date
Betsy M. Natz Executive Director Dear Ms. Natz:
NTP — Anthraquinone Abstract: HHS Response to Rfr
Publication Date
September 8, 2003 Mr. Jerry A. Cook Technical Director Chemical Products Corporation Cartersville, Georgia 30120 Re: Request for Reconsideration submitted March 27, 2003 Dear Mr. Cook:
CDC/ATSDR — Formaldehyde Levels: b.7. Interim Response
Publication Date
Betsy M. Natz Executive DirectorThe Fonnaldehyde Council, IncNorth Quincy Street, Suite 700Arlington, V A 22203 Dear Ms. Natz:
NTP — Atrazine: HHS Response to RFC, May 25, 2005
Publication Date
Date: May 25, 2005 To Mr. Jim Tozzi, Center for Regulatory Effectiveness Dear Mr. Tozzi: From: National Institutes of Health, National Institute of Environmental Health Sciences
FDA — Genasense: Interim Response, AUG 24, 2007
Publication Date
NDA 21-649 Ms. Nancy L. BucMs. Deborah LivorneseBuc & Beardsley919 Eighteenth Street, N.W.Washington, D.C. 20006-5503 Dear Ms. Buc and Ms. Livornese:
FDA — Genasense: Interim Response, October 22, 2007
Publication Date
NDA 21-649 Ms. Nancy L. BucMs. Deborah LivorneseBuc & Beardsley919 Eighteenth Street,N.W. Washington, D.C. 20006-5503 Dear Ms. Buc and Ms. Livornese:
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, March 21, 2012
Publication Date
March 21, 2012 Paul HagemeierChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, May 21, 2012
Publication Date
May 21, 2012 Paul HagemeierChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
CDC — Fluoroquinolone: Request for Reconsideration (RFR)
Publication Date
March 27, 2003 VIA FEDEX and E-MAIL (w/o Attachments) CDC/ATSDR MASO/MS-E11 1600 Clifton Road, N.E. Atlanta, GA 30333 Information Quality Appeal
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, July 20. 2012
Publication Date
July 20. 2012 Paul I HagemeierChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, September 20, 2012
Publication Date
September 20, 2012 Paul Hagemeier Chesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
NTP — Anthraquinone Report: Request for Correction (RFC)
Publication Date
February 24, 2004 Associate Director for Communications Office of the Director National Institutes of Health Building 1, Room 344 9000 Rockville Pike Bethesda, MD 20892